There are no treatments or vaccines approved for Marburg, a virus in the same family as Ebola with a fatality rate between 24 ...
A similar vaccine, being developed at the University of Oxford, UK, was also named as a priority for testing during a Marburg ...
Zacks Small Cap Research on MSN1d
SNGX: Marburg Outbreak Puts Focus on Soligenix Vaccine Development…(NASDAQ:SNGX) is developing vaccines targeting multiple filoviruses, including MarVax™, a heat stable vaccine for protection ...
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...
Six people in Rwanda, primarily medical professionals, have died from the Marburg virus since the outbreak was declared. This ...
Six people have died, and 20 others are being treated for Marburg virus disease in Rwanda. This is the first-ever outbreak of ...
Good morning! What would you buy if you earned $305 million in one year? Maybe I'd have a different color KitchenAid mixer ...
Researchers are developing a new generation of antiviral drugs that target the membranes of viruses instead of the surface proteins. These drugs, inspired by our immune system, show promise against ...
The injuries led an animal rights group to file a workplace safety complaint. But federal inspectors declined to visit the ...
The injuries led an animal rights group to file a workplace safety complaint. But federal inspectors declined to visit the ...
News Medical on MSN5d
How viral persistence and immune dysfunction drive long COVIDStudy explores the biological drivers and mechanisms of long COVID, shedding light on its epidemiology and potential ...
A therapy showing promise to help control tuberculosis does not interfere with combined antiretroviral therapy (cART), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback